Literature DB >> 7723969

Neuropathy profile of diabetic patients in a pancreas transplantation program.

W R Kennedy1, X Navarro, D E Sutherland.   

Abstract

We describe the results of extensive neurologic evaluation of 290 patients with insulin-dependent diabetes mellitus who came to our institution as potential recipients of a pancreas transplant. Large nerve fibers were evaluated by motor and sensory nerve conduction, small sensory fibers by thermal sensation thresholds, vagal and vasomotor functions by cardiovascular reflexes, and sympathetic sudomotor fibers by silicone imprints and evaporimetry. A scored anamnesis revealed symptoms of neuropathy in 86% of patients; 94% had an abnormal neurologic examination. The most frequently abnormal measurements of motor conduction were the amplitude of the extensor digitorum brevis muscle action potential to peroneal nerve stimulation and the conduction velocity of peroneal and tibial nerves in more than 80% of patients. Sensory nerve action potentials were abnormal in 76% and the distal latency of the sural nerve in 91%. Heart rate variability with deep breathing and during a Valsalva's maneuver was abnormal in 90% and 88%. Sudomotor function was reduced in 59% on the foot. Thermal sensitivity limen was above normal limits in 95% in the foot and 77% in the hand. Composite indexes of the degree of abnormality found for each type of function tested were correlated one with another, but were not predictive of results for any other test. The neuropathy of most patients was symmetric, involving to a similar degree motor, sensory, and autonomic nerves. Thus, diabetic neuropathy is very common and severe among patients who decide to be candidates for pancreas transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7723969     DOI: 10.1212/wnl.45.4.773

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.

Authors:  Tatiane M Murça; Tatiane C S Almeida; Mohan K Raizada; Anderson J Ferreira
Journal:  Exp Physiol       Date:  2012-01-27       Impact factor: 2.969

3.  Diagnostic Accuracy of Random ECG in Primary Care for Early, Asymptomatic Cardiac Autonomic Neuropathy.

Authors:  Herbert F Jelinek; Marc T P Adam; Robert Krones; David J Cornforth
Journal:  J Diabetes Sci Technol       Date:  2017-04-13

4.  Assessment of autonomic symptoms in a medically complex, urban patient population.

Authors:  Jessica Robinson-Papp; Sandeep K Sharma; Mary Catherine George; David M Simpson
Journal:  Clin Auton Res       Date:  2016-10-12       Impact factor: 4.435

Review 5.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

Review 6.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

7.  Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy?

Authors:  M M Selim; G Wendelschafer-Crabb; J B Redmon; A Khoruts; J S Hodges; K Koch; D Walk; W R Kennedy
Journal:  Neurology       Date:  2010-09-14       Impact factor: 9.910

Review 8.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

9.  Advanced Diabetic Neuropathy: A Point of no Return?

Authors:  Petr Boucek
Journal:  Rev Diabet Stud       Date:  2006-11-10

Review 10.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.